156 related articles for article (PubMed ID: 9256944)
1. The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users.
Lyles CM; Margolick JB; Astemborski J; Graham NM; Anthony JC; Hoover DR; Vlahov D
AIDS; 1997 Aug; 11(10):1255-62. PubMed ID: 9256944
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users.
Margolick JB; Muñoz A; Vlahov D; Astemborski J; Solomon L; He XY; Nelson KE; Saah AJ
Arch Intern Med; 1994 Apr; 154(8):869-75. PubMed ID: 7908795
[TBL] [Abstract][Full Text] [Related]
3. New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4+ decline among HIV-infected injecting drug users.
Krol A; Flynn C; Vlahov D; Miedema F; Coutinho RA; van Ameijden EJ
Drug Alcohol Depend; 1999 Apr; 54(2):145-54. PubMed ID: 10217554
[TBL] [Abstract][Full Text] [Related]
4. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in rate of CD4 decline in HIV-1-infected homosexual men.
Easterbrook PJ; Farzadegan H; Hoover DR; Palenicek J; Chmiel JS; Kaslow RA; Saah AJ
AIDS; 1996 Sep; 10(10):1147-55. PubMed ID: 8874633
[TBL] [Abstract][Full Text] [Related]
6. Alcohol use and T-lymphocyte subsets among injection drug users with HIV-1 infection: a prospective analysis.
Crum RM; Galai N; Cohn S; Celentano DD; Vlahov D
Alcohol Clin Exp Res; 1996 Apr; 20(2):364-71. PubMed ID: 8730231
[TBL] [Abstract][Full Text] [Related]
7. Laboratory markers and the risk of developing HIV-1 disease among injecting drug users.
Alcabes P; Selwyn PA; Davenny K; Hartel D; Buono D; Schoenbaum EE; Klein RS; Friedland GH
AIDS; 1994 Jan; 8(1):107-15. PubMed ID: 7912083
[TBL] [Abstract][Full Text] [Related]
8. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland.
Vlahov D; Muñoz A; Anthony JC; Cohn S; Celentano DD; Nelson KE
Am J Epidemiol; 1990 Nov; 132(5):847-56. PubMed ID: 2239899
[TBL] [Abstract][Full Text] [Related]
9. Injecting drug use is associated with a more rapid CD4 cell decline among treatment naïve HIV-positive patients in Indonesia.
Meijerink H; Wisaksana R; Iskandar S; den Heijer M; van der Ven AJ; Alisjahbana B; van Crevel R
J Int AIDS Soc; 2014; 17(1):18844. PubMed ID: 24388495
[TBL] [Abstract][Full Text] [Related]
10. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men.
Galai N; Vlahov D; Margolick JB; Chen K; Graham NM; Muñoz A
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):66-74. PubMed ID: 8548349
[TBL] [Abstract][Full Text] [Related]
11. CD4+ lymphocyte level and rate of decline as predictors of AIDS in intravenous drug users with HIV infection.
Alcabes P; Schoenbaum EE; Klein RS
AIDS; 1993 Apr; 7(4):513-7. PubMed ID: 8099488
[TBL] [Abstract][Full Text] [Related]
12. Disparity in the percentage of CD4+ T lymphocytes and prognosis of HIV-infected intravenous drug users in Malaysia.
Norazmi MN; Suarn S
Immunol Lett; 1994 Dec; 43(3):177-82. PubMed ID: 7721330
[TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men.
Burack JH; Barrett DC; Stall RD; Chesney MA; Ekstrand ML; Coates TJ
JAMA; 1993 Dec; 270(21):2568-73. PubMed ID: 7901433
[TBL] [Abstract][Full Text] [Related]
14. Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users.
Prins M; Hernández Aguado IH; Brettle RP; Robertson JR; Broers B; Carré N; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
AIDS; 1997 Nov; 11(14):1747-56. PubMed ID: 9386810
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
16. Correlates of the rate of decline of CD4+ lymphocytes among injection drug users infected with the human immunodeficiency virus.
Alcabes P; Schoenbaum EE; Klein RS
Am J Epidemiol; 1993 May; 137(9):989-1000. PubMed ID: 8100395
[TBL] [Abstract][Full Text] [Related]
17. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D
J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535
[TBL] [Abstract][Full Text] [Related]
18. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
[TBL] [Abstract][Full Text] [Related]
19. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users.
Mientjes GH; Miedema F; van Ameijden EJ; van den Hoek AA; Schellekens PT; Roos MT; Coutinho RA
AIDS; 1991 Jan; 5(1):35-41. PubMed ID: 1829366
[TBL] [Abstract][Full Text] [Related]
20. Existence and failure of T-cell homeostasis prior to AIDS onset in HIV-infected injection drug users.
Galai N; Margolick JB; Astemborski J; Vlahov D
Clin Immunol Immunopathol; 1996 May; 79(2):134-41. PubMed ID: 8620619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
